Patents Assigned to The University of Miami
-
Patent number: 12290314Abstract: A system for ophthalmic imaging comprising an ophthalmic device configured to obtain stereoscopic images of an eye of a patient and to transmit the images in real-time to a display device via a network for viewing by practitioners. The ophthalmic device comprises at least an optic assembly, a processing assembly, a slit assembly, such as a slit lamp, and a positioning assembly. Control devices structured to control the ophthalmic device over the network, such as the world wide web, can be disposed at a plurality of locations, and may be remote from the ophthalmic device while providing real time control of the parameters of the ophthalmic device by the practitioner(s) associated therewith.Type: GrantFiled: February 28, 2020Date of Patent: May 6, 2025Assignee: University of MiamiInventors: Jean-Marie Parel, Alex Gonzalez, Eric Buckland, Cornelis Jan Rowaan, Florence Cabot
-
Patent number: 12275725Abstract: Disclosed herein are inhibitors of the Notch transcriptional activation complex, and methods for their use in treating or preventing diseases, such as cancer. The inhibitors described herein can include compounds of Formula (I) and pharmaceutically acceptable salts thereof: Formula (I), wherein the substituents are as described.Type: GrantFiled: February 11, 2020Date of Patent: April 15, 2025Assignees: University of Miami, StemSynergy Therapeutics, Inc.Inventors: Anthony J. Capobianco, Mark Spyvee, Luisana Astudillo, Darren Orton
-
Publication number: 20250073277Abstract: The disclosure provides a method of obtaining a population of cardiomyogenic precursor cells. The method comprises (a) differentiating induced pluripotent stem cells (iPSCs) to iPSC-derived cardiac precursor cells; and (b) isolating cardiac precursor cells expressing mammalian growth hormone-releasing hormone receptor (GHRHR) to obtain a population of iPSC-derived cardiomyogenic precursor cells.Type: ApplicationFiled: November 18, 2024Publication date: March 6, 2025Applicant: University of MiamiInventors: Joshua M. HARE, Konstantinos CHATZISTERGOS
-
Publication number: 20250040800Abstract: In some embodiments, initial feedback indicating threshold characteristics (under which a user sees initial stimuli presented on a user interface) may be provided to a prediction model, and a set of predicted characteristics (for a set of locations of the user interface) may be obtained via the prediction model. Based on predicted characteristics associated with one or more selected locations, stimuli may be presented at the selected locations during the visual test presentation. Visual defect information for the user may be generated based on feedback from the visual test presentation. In some embodiments, the selection of the locations to be tested during a visual test presentation may be performed based on a set of confidence scores associated with the predicted characteristics. As an example, the locations may be selected over one or more other locations of the set of locations based on the set of confidence scores.Type: ApplicationFiled: October 23, 2024Publication date: February 6, 2025Applicant: University of MiamiInventor: Mohamed Abou Shousha
-
Publication number: 20250009222Abstract: In some embodiments, image content may be presented to a user of a head-mounted device via one or more inward-facing displays of the head-mounted device. Light emitted from one or more infrared diodes may be projected onto an eye of the user via one or more inward-facing infrared devices of the head-mounted device. Reflection data related to a reflection of the infrared-diode-emitted light reflected from the eye may be obtained via the one or more inward-facing infrared devices of the head-mounted device. A machine learning model (e.g., comprising a neural network or other components) may be used to generate an eye-related indication based on the reflection data comprising one or more anomalies.Type: ApplicationFiled: September 23, 2024Publication date: January 9, 2025Applicant: University of MiamiInventor: Mohamed Abou Shousha
-
Patent number: 12167904Abstract: Devices, systems, and methods for remotely and, optionally, continuously, reading a temperature of an object, such as a human. In one embodiment, a temperature sensor patch comprises: a sensor circuit, the sensor circuit including: a radiofrequency identification (RFID) chip; and an antenna; and a layer of base material, the sensor circuit being in the layer of material and the layer of base material being configured to permit a signal transfer between the sensor circuit and a surrounding environment.Type: GrantFiled: April 22, 2021Date of Patent: December 17, 2024Assignees: Biotags, LLC, University of MiamiInventors: Brian Arwari, Luis Carlos Diaz Bautista
-
Patent number: 12168028Abstract: The disclosure provides a method of obtaining a population of cardiomyogenic precursor cells. The method comprises (a) differentiating induced pluripotent stem cells (iPSCs) to iPSC-derived cardiac precursor cells; and (b) isolating cardiac precursor cells expressing mammalian growth hormone-releasing hormone receptor (GHRHR) to obtain a population of iPSC-derived cardiomyogenic precursor cells.Type: GrantFiled: September 21, 2018Date of Patent: December 17, 2024Assignee: UNIVERSITY OF MIAMIInventors: Joshua M. Hare, Konstantinos Chatzistergos
-
Patent number: 12133683Abstract: Methods and systems for dynamically determining stimuli characteristics for vision defect determination during a vision test. The methods and systems convert the feedback received from the binary suprathreshold test into a feature input that is provided to a prediction model. The prediction model may be trained to predict non-binary characteristics for sets of locations and confidence scores associated with the sets of locations based on feedback indicating binary characteristics under which users see one or more stimuli presented on user interfaces.Type: GrantFiled: August 3, 2021Date of Patent: November 5, 2024Assignee: University of MiamiInventor: Mohamed Abou Shousha
-
Patent number: 12096982Abstract: In certain embodiments, double-vision-related vision defects determinations or modifications may be facilitated. In some embodiments, a stimulus may be to be presented at a first time at a position on a first display for a deviating eye of a user (e.g., without a stimulus being presented on a second display of for a reference eye of the user) to cause the deviating eye to fixate on the position on the first display. A deviation measurement for the deviating eye may be determined based on an amount of movement of the deviating eye occurring upon the presentation on the first display for the deviating eye at the first time. In some embodiments, a modification profile associated with the user may be determined based on the deviation measurement, where the modification profile includes one or more modification parameters to be applied to modify an image for the user.Type: GrantFiled: May 18, 2023Date of Patent: September 24, 2024Assignee: University of MiamiInventor: Mohamed Abou Shousha
-
Patent number: 12090262Abstract: A device, kit, and method for aspirating graft tissue and delivering the graft tissue to a target delivery site. An injector comprises a cylinder and a plunger that is both linearly and rotatably advanceable and retractable within the cylinder. A kit comprises an injector, a cartridge, and a cartridge coupling element that connects the cartridge to the injector. The kit may also include a container that is configured to retain a cartridge and to facilitate connection between the injector and the cartridge. The container includes at least one fluid barrier that prevents spillage of storage solution from the container when the injector is at least partially inserted into the well of the container.Type: GrantFiled: September 1, 2021Date of Patent: September 17, 2024Assignees: TissueCor, LLC, University of MiamiInventors: Alfonso L. Sabater, William B. Buras, Alejandro M. Sabater, Daniel J. Duminuco, Michael A. Botta
-
Publication number: 20240298976Abstract: A system measures performance activity of a user using a motion capture device, such as one or more knee sleeves each a plurality of inertial-measurement unit. Captured motion characteristic data is classified against previously captured data and then mapped to particular audio effects, which are then altered in different ways depending on the classification and provided the user. The audio feedback works to improve the user's performance of the activity by changing between negative and positive feedback depending on the user's performance. The system regularly measures the motion capture data, altering audio effects provided to the user, until the user reaches an improvement goal.Type: ApplicationFiled: May 16, 2024Publication date: September 12, 2024Applicant: University of MiamiInventors: Christopher Bennett, Robert Gailey, Vibhor Agrawal, Colby Leider
-
Patent number: 12083168Abstract: The present disclosure relates to methods of detecting and treating inherited neuropathy.Type: GrantFiled: April 13, 2022Date of Patent: September 10, 2024Assignees: University of Miami, University of Rochester, UCL Business LTDInventors: Stephan L. Zuchner, Adriana Rebelo, Andrea Cortese, Rong Grace Zhai, David N. Herrmann
-
Patent number: 12084483Abstract: Various methods and compositions are provided which can be employed to modulate the immune system. Compositions include a fusion protein comprising: (a) a first polypeptide comprising Interleukin-2 (IL-2) or a functional variant or fragment thereof; and (b) a second polypeptide, fused in frame to the first polypeptide, wherein the second polypeptide comprises an extracellular domain of Interleukin-2 Receptor alpha (IL-2R?) or a functional variant or fragment thereof, and wherein the fusion protein has IL-2 activity. Various methods are provided for modulating the immune response in a subject comprising administering to a subject in need thereof a therapeutically effective amount of the IL-2/IL-2R? fusion protein disclosed herein.Type: GrantFiled: August 5, 2015Date of Patent: September 10, 2024Assignee: University of MiamiInventor: Thomas Malek
-
Patent number: 12077508Abstract: Disclosed herein are Notch transcriptional activation complex kinase (“MACK”) inhibitors, and methods for their use in treating or preventing diseases, such as cancer. The inhibitors described herein include compounds of Formula (Ia) and pharmaceutically acceptable salts thereof: wherein the substituents are as described.Type: GrantFiled: September 6, 2022Date of Patent: September 3, 2024Assignee: University of MiamiInventors: Anthony J. Capobianco, Stephan C. Schürer, Xiaoxia Zhu, Tanya T. Kelley
-
Patent number: 12066512Abstract: Systems and methods provide a parallelized deep learning approach to spectral fitting for magnetic resonance spectroscopy data enabling accurate and rapid spectral fitting and determination of metabolite measurements using a conventional computer. The method may include processing multi-spectra magnetic resonance (MR) spectroscopy data of a region of interest through a series of neural networks. The method may include determining baseline components of each spectrum using a first neural network of the series, generating baseline-corrected components for each spectrum using the baseline components; and determining one or more peak components of each spectrum using a second neural network of the series and the baseline-corrected components. The method may further include determining one or more metabolite measurements of the one or more metabolites in the region of interest using the one or more peak components.Type: GrantFiled: November 20, 2019Date of Patent: August 20, 2024Assignees: Emory University, University of MiamiInventors: Hyunsuk Shim, Lee Cooper, Saumya Gurbani, Andrew Maudsley, Sulaiman Sheriff
-
Patent number: 12029706Abstract: The present invention provides methods and compositions for the treatment of mucopolysaccharidoses (MPS).Type: GrantFiled: September 15, 2020Date of Patent: July 9, 2024Assignee: University of MiamiInventors: Shaun Brothers, Claes Wahlestedt, Claude Henry Volmar
-
Publication number: 20240200046Abstract: Disclosed herein are recombinant meganucleases engineered to recognize and cleave a recognition sequence present in the human mitochondrial DNA (mtDNA). The disclosure further relates to the use of such recombinant meganucleases in combination with mitochondrial transit peptides in methods for producing genetically-modified eukaryotic cells, and to a population of genetically-modified eukaryotic cells wherein the mtDNA has been modified or edited.Type: ApplicationFiled: April 22, 2022Publication date: June 20, 2024Applicants: Precision BioSciences, Inc., University of MiamiInventors: Carlos T. Moraes, James Jefferson Smith, Derek Jantz, Ginger H. Tomberlin, John Morris, Wendy Shoop
-
Publication number: 20240181015Abstract: Provided herein are compositions and methods of use thereof for the treatment of metabolic disease such as diabetes and obesity. One embodiment provides a method of treating a metabolic disease or syndrome in a subject in need thereof by administering to the subject a therapeutically effective amount of a growth hormone releasing hormone (GHRH) antagonist or a pharmaceutical composition comprising the GHRH antagonist to reduce triglyceride-rich-lipoproteins (TRL) in the subject to treat the metabolic condition or syndrome.Type: ApplicationFiled: April 4, 2022Publication date: June 6, 2024Applicants: AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC., UNIVERSITY OF MIAMI, THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPT. OF VETERANS AFFAIRSInventors: Neal L. WEINTRAUB, Maritza J. ROMERO LUCAS, Rudolf LUCAS, Andrew SCHALLY, Renzhi CAI
-
Patent number: D1054593Type: GrantFiled: August 16, 2022Date of Patent: December 17, 2024Assignee: University of MiamiInventors: Esber Andiroglu, Nancy Lewis
-
Patent number: D1054594Type: GrantFiled: August 16, 2022Date of Patent: December 17, 2024Assignee: University of MiamiInventors: Esber Andiroglu, Nancy Lewis